Results 91 to 100 of about 4,912,345 (213)

Drug-induced akathisia - a preliminary report.

open access: yesIndian journal of psychiatry, 2011
25 in-patients, 17 males and 8 females, were administered Barnes' Scale for drug-induced Akathisia. Akathisia was found in 7 of them, 5 males and 2 females. One had pseudoakathisia and in the other, akathisia was questionable. The inter-rater reliability, assessed by weighted Cohen's kappa, was found to be high.
D, Ray, J, Samajdar, R, Khanna
openaire   +1 more source

Beyond the Homunculus—SCAN‐AMN as a Shared Action‐Oriented Neural Substrate across Movement Disorders

open access: yes
Movement Disorders, Volume 41, Issue 6, Page 1349-1354, June 2026.
Arjun Balachandar   +4 more
wiley   +1 more source

Severe extrapyramidal symptoms due to valproate plus low dose olanzapine: A case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
In many studies comparing extrapyramidal system (EPS) side effects due to olanzapine and other atypical antipsychotics, it has been shown that olanzapine induces these effects less than risperidone and comparable to clozapine.
Demet Dankı   +2 more
doaj  

Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat [PDF]

open access: yes, 2012
Improved biomarkers of acute nephrotoxicity are coveted by the drug development industry, regulatory agencies, and clinicians. In an effort to identify such biomarkers, urinary peptide profiles of rats treated with two different nephrotoxins were ...
Hanig, J.   +23 more
core   +2 more sources

Olfactory dysfunction as a diagnostic and prognostic marker for movement disorders

open access: yesAnnals of Movement Disorders
Olfactory dysfunction (OD) is a common nonmotor symptom observed in several movement disorders. The severity and pattern of olfactory impairment vary among these conditions.
Aliasghar Peyvandi   +7 more
doaj   +1 more source

Clozapine-induced acute akathisia: A case report

open access: yes
Existing data suggest that clozapine has lesser propensity of developing akathisia as compared to first general antipsychotics. Clozapine is mostly used in patients with treatment-resistant schizophrenia, which is a second-generation antipsychotic ...
Neena Bhatti   +3 more
core   +1 more source

Akathisia

open access: yes, 2010
Akathisia is characterized by a subjective report of inner restlessness and inability to sit still, relieved by moving about. When sitting, the patient usually has repetitive movements that involve primarily the legs and trunk.
A.E. Lang   +5 more
core   +1 more source

A Case Report and Literature Review of Fluoxetine-Induced Akathisia in a Patient with Depression [PDF]

open access: yes
Akathisia is a movement disorder characterized by an overwhelming and uncontrollable need to move. It is generally connected with the use of antipsychotic medications, with just a few cases found to be produced by selective serotonin reuptake inhibitors.
zaenb Alsalman
core   +1 more source

A trial of midazolam vs diphenhydramine in prophylaxis of metoclopramide-induced akathisia

open access: yes, 2012
Study Objective: The study aimed to evaluate the effects of midazolam and diphenhydramine for the prevention of metoclopramide-induced akathisia. Methods: This randomized, double-blind, and controlled trial aimed to investigate coadministered midazolam ...
Kabay, Burhan   +13 more
core   +1 more source

No association between akathisia or Parkinsonism and suicidality in treatment-resistant schizophrenia

open access: yes, 2004
Akathisia and drug-induced Parkinsonism have traditionally been associated with depression and suicidality based on case study evidence. In this subanalysis, patients with treatment resistant schizophrenia were rated on the Comprehensive ...
Hansen, L.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy